Literature DB >> 29955945

Association of gout with osteoporotic fractures.

Yanmao Wang1, Runhua Zhou1, Wanrun Zhong1, Chengfang Hu1, Shengdi Lu2, Yimin Chai3.   

Abstract

PURPOSE: Previous studies have shown that serum uric acid levels and inflammation are associated with bone mineral density. Gout, a disease characterized by hyperuricemia and inflammation, contributes to the risk of osteoporotic fractures. However, this association is controversial. Therefore, this study investigated whether gout in older people (age > 55 years) is associated with osteoporotic fracture risk.
METHODS: This population-based, cross-sectional study included 2674 participants (147 cases of gout and 388 fractures). Standardized and self-administered questionnaires were employed and physical examinations, blood tests, and bone mineral density examinations were performed; multivariate-adjusted logistic regression models were used to evaluate associations between gout and osteoporotic fracture risk.
RESULTS: The data were adjusted for age; smoking status; alcohol status; physical activity; body mass index; waist circumference; hypertension; cardiovascular events; diabetes mellitus; rheumatoid arthritis; serum levels of total cholesterol (TC), triglycerides, and high- and low-density lipids; and T-scores. We found a significant association between gout and osteoporotic fracture risk in women (odds ratio [OR], 2.00; 95% confidence interval [CI], 1.12-3.56; P = 0.019), but no such association in men (OR, 1.30; 95% CI, 0.58-2.88; P = 0.525). Further stratified analyses showed a significant association between gout and osteoporotic fracture risk in women without rheumatic arthritis and in those with high TC levels or with osteoporosis (all, P < 0.05).
CONCLUSIONS: In older Chinese adults, gout is significantly associated with the risk of osteoporotic fractures in women, especially those without rheumatic arthritis and in those with high TC levels or with osteoporosis.

Entities:  

Keywords:  Cross-sectional studies; Fracture; Gout; Osteoporosis; Risk factor

Mesh:

Substances:

Year:  2018        PMID: 29955945     DOI: 10.1007/s00264-018-4033-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  34 in total

1.  Serum uric acid levels in relation to bone-related phenotypes in men and women.

Authors:  Chanika Sritara; Boonsong Ongphiphadhanakul; Laor Chailurkit; Sukit Yamwong; Wipa Ratanachaiwong; Piyamitr Sritara
Journal:  J Clin Densitom       Date:  2012-06-21       Impact factor: 2.617

2.  Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout.

Authors:  S Takahashi; T Yamamoto; Y Moriwaki; Z Tsutsumi; J Yamakita; K Higashino
Journal:  Metabolism       Date:  1998-03       Impact factor: 8.694

3.  Adult dyslipidemia prediction is improved by repeated measurements in childhood and young adulthood. The Cardiovascular Risk in Young Finns Study.

Authors:  Joel Nuotio; Mervi Oikonen; Costan G Magnussen; Jorma S A Viikari; Nina Hutri-Kähönen; Antti Jula; Russell Thomson; Matthew A Sabin; Stephen R Daniels; Olli T Raitakari; Markus Juonala
Journal:  Atherosclerosis       Date:  2015-02-07       Impact factor: 5.162

4.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

Review 5.  Inflammatory signaling induced bone loss.

Authors:  Steven R Goldring
Journal:  Bone       Date:  2015-05-28       Impact factor: 4.398

6.  Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study.

Authors:  Tapan Mehta; Petra Bůžková; Mark J Sarnak; Michel Chonchol; Jane A Cauley; Erin Wallace; Howard A Fink; John Robbins; Diana Jalal
Journal:  Metabolism       Date:  2014-11-21       Impact factor: 8.694

7.  Homocysteine levels and the risk of osteoporotic fracture.

Authors:  Joyce B J van Meurs; Rosalie A M Dhonukshe-Rutten; Saskia M F Pluijm; Marjolein van der Klift; Robert de Jonge; Jan Lindemans; Lisette C P G M de Groot; Albert Hofman; Jacqueline C M Witteman; Johannes P T M van Leeuwen; Monique M B Breteler; Paul Lips; Huibert A P Pols; André G Uitterlinden
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

Review 8.  Osteoporosis and inflammation.

Authors:  Gregory R Mundy
Journal:  Nutr Rev       Date:  2007-12       Impact factor: 7.110

9.  The independent association between parathyroid hormone levels and hyperuricemia: a national population study.

Authors:  Janet Y Hui; Jee Woong J Choi; David B Mount; Yanyan Zhu; Yuqing Zhang; Hyon K Choi
Journal:  Arthritis Res Ther       Date:  2012-03-10       Impact factor: 5.156

Review 10.  Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss.

Authors:  Tania N Crotti; Anak A S S K Dharmapatni; Ekram Alias; David R Haynes
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

View more
  2 in total

1.  Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases.

Authors:  Zhuoran Hu; Shuiming Xu; He Lin; Weifeng Ni; Qingyuan Yang; Jun Qi; Keqian Du; Jieruo Gu; Zhiming Lin
Journal:  BMC Musculoskelet Disord       Date:  2020-06-30       Impact factor: 2.362

2.  High-Throughput Metabolomics Evaluate the Efficacy of Total Lignans From Acanthophanax Senticosus Stem Against Ovariectomized Osteoporosis Rat.

Authors:  Ai-Hua Zhang; Zhi-Ming Ma; Hui Sun; Ying Zhang; Jian-Hua Liu; Fang-Fang Wu; Xi-Jun Wang
Journal:  Front Pharmacol       Date:  2019-05-29       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.